Establishment of Diagnosis and Classification System for Lung Interstitial and Airway Diseases (LIAD)

NCT06987266 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2025-05-23

No results posted yet for this study

Summary

This study focuses on both hospitalized and outpatient populations. Through a multicenter, retrospective study, it aims to comprehensively characterize:The comorbidity of interstitial lung diseases (ILD) and airway diseases;The comorbidity of ILD with other intrapulmonary diseases;The comorbidity of airway diseases with other intrapulmonary diseases;The comorbidity of ILD and airway diseases with extrapulmonary diseases.Based on these findings, the study seeks to propose classification and diagnostic criteria for ILD and airway disease comorbidities.Additionally, a multicenter, prospective, disease-specific cohort study will be conducted to observe the prognosis of patients with ILD and/or airway diseases, identify prognostic factors, and grade the severity of comorbid conditions based on these factors.Finally, the study will analyze the current state of interventions and the medical costs associated with ILD and airway disease comorbidities through a cost-effectiveness analysis, aiming to propose new strategies for integrated disease management.

Conditions

  • Interstitial Lung Diseases (ILD)
  • Airway Disease

Interventions

OTHER

no intervention

no ntervention

Sponsors & Collaborators

  • Beijing Hospital

    collaborator OTHER_GOV
  • Henan Provincial People's Hospital

    collaborator OTHER
  • Zhejiang University

    collaborator OTHER
  • Zhongshan Hospital (Xiamen), Fudan University

    collaborator OTHER
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • The Affiliated Hospital Of Guizhou Medical University

    collaborator OTHER
  • China-Japan Friendship Hospital

    collaborator OTHER
  • First Hospital of China Medical University

    collaborator OTHER
  • Xiangya Hospital of Central South University

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-20
Primary Completion
2028-11-30
Completion
2028-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06987266 on ClinicalTrials.gov